Global Human Insulin Market Insights and Forecast to 2031

Report ID: 1379828 | Published Date: Sep 2024 | No. of Page: 111 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Insulin Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Insulin Analogs and Biosimilars
        1.2.3 Human Insulin Biologics
    1.3 Market by Application
        1.3.1 Global Human Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Short Acting
        1.3.3 Intermediate Acting
        1.3.4 Long Acting
        1.3.5 Pre-Mix Insulin
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Insulin Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Insulin Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Insulin Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Insulin Sales by Region
        2.4.1 Global Human Insulin Sales by Region (2017-2022)
        2.4.2 Global Sales Human Insulin by Region (2023-2028)
    2.5 Global Human Insulin Revenue by Region
        2.5.1 Global Human Insulin Revenue by Region (2017-2022)
        2.5.2 Global Human Insulin Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Insulin Sales by Manufacturers
        3.1.1 Global Top Human Insulin Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Insulin Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Insulin in 2021
    3.2 Global Human Insulin Revenue by Manufacturers
        3.2.1 Global Human Insulin Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Insulin Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Revenue in 2021
    3.3 Global Human Insulin Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Insulin Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Insulin Sales by Type
        4.1.1 Global Human Insulin Historical Sales by Type (2017-2022)
        4.1.2 Global Human Insulin Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Insulin Sales Market Share by Type (2017-2028)
    4.2 Global Human Insulin Revenue by Type
        4.2.1 Global Human Insulin Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Insulin Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Insulin Revenue Market Share by Type (2017-2028)
    4.3 Global Human Insulin Price by Type
        4.3.1 Global Human Insulin Price by Type (2017-2022)
        4.3.2 Global Human Insulin Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Insulin Sales by Application
        5.1.1 Global Human Insulin Historical Sales by Application (2017-2022)
        5.1.2 Global Human Insulin Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Insulin Sales Market Share by Application (2017-2028)
    5.2 Global Human Insulin Revenue by Application
        5.2.1 Global Human Insulin Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Insulin Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Insulin Revenue Market Share by Application (2017-2028)
    5.3 Global Human Insulin Price by Application
        5.3.1 Global Human Insulin Price by Application (2017-2022)
        5.3.2 Global Human Insulin Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Insulin Market Size by Type
        6.1.1 North America Human Insulin Sales by Type (2017-2028)
        6.1.2 North America Human Insulin Revenue by Type (2017-2028)
    6.2 North America Human Insulin Market Size by Application
        6.2.1 North America Human Insulin Sales by Application (2017-2028)
        6.2.2 North America Human Insulin Revenue by Application (2017-2028)
    6.3 North America Human Insulin Market Size by Country
        6.3.1 North America Human Insulin Sales by Country (2017-2028)
        6.3.2 North America Human Insulin Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Human Insulin Market Size by Type
        7.1.1 Europe Human Insulin Sales by Type (2017-2028)
        7.1.2 Europe Human Insulin Revenue by Type (2017-2028)
    7.2 Europe Human Insulin Market Size by Application
        7.2.1 Europe Human Insulin Sales by Application (2017-2028)
        7.2.2 Europe Human Insulin Revenue by Application (2017-2028)
    7.3 Europe Human Insulin Market Size by Country
        7.3.1 Europe Human Insulin Sales by Country (2017-2028)
        7.3.2 Europe Human Insulin Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Insulin Market Size by Type
        8.1.1 Asia Pacific Human Insulin Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Insulin Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Insulin Market Size by Application
        8.2.1 Asia Pacific Human Insulin Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Insulin Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Insulin Market Size by Region
        8.3.1 Asia Pacific Human Insulin Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Insulin Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Human Insulin Market Size by Type
        9.1.1 Latin America Human Insulin Sales by Type (2017-2028)
        9.1.2 Latin America Human Insulin Revenue by Type (2017-2028)
    9.2 Latin America Human Insulin Market Size by Application
        9.2.1 Latin America Human Insulin Sales by Application (2017-2028)
        9.2.2 Latin America Human Insulin Revenue by Application (2017-2028)
    9.3 Latin America Human Insulin Market Size by Country
        9.3.1 Latin America Human Insulin Sales by Country (2017-2028)
        9.3.2 Latin America Human Insulin Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Insulin Market Size by Type
        10.1.1 Middle East and Africa Human Insulin Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Insulin Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Insulin Market Size by Application
        10.2.1 Middle East and Africa Human Insulin Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Insulin Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Insulin Market Size by Country
        10.3.1 Middle East and Africa Human Insulin Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Insulin Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 B. Braun
        11.1.1 B. Braun Corporation Information
        11.1.2 B. Braun Overview
        11.1.3 B. Braun Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 B. Braun Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 B. Braun Recent Developments
    11.2 Becton, Dickinson
        11.2.1 Becton, Dickinson Corporation Information
        11.2.2 Becton, Dickinson Overview
        11.2.3 Becton, Dickinson Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Becton, Dickinson Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Becton, Dickinson Recent Developments
    11.3 Biocon
        11.3.1 Biocon Corporation Information
        11.3.2 Biocon Overview
        11.3.3 Biocon Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Biocon Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Biocon Recent Developments
    11.4 Biodel
        11.4.1 Biodel Corporation Information
        11.4.2 Biodel Overview
        11.4.3 Biodel Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Biodel Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Biodel Recent Developments
    11.5 ELI Lilly
        11.5.1 ELI Lilly Corporation Information
        11.5.2 ELI Lilly Overview
        11.5.3 ELI Lilly Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 ELI Lilly Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 ELI Lilly Recent Developments
    11.6 Julphar
        11.6.1 Julphar Corporation Information
        11.6.2 Julphar Overview
        11.6.3 Julphar Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Julphar Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Julphar Recent Developments
    11.7 NOVO Nordisk
        11.7.1 NOVO Nordisk Corporation Information
        11.7.2 NOVO Nordisk Overview
        11.7.3 NOVO Nordisk Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 NOVO Nordisk Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 NOVO Nordisk Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Corporation Information
        11.8.2 Sanofi Overview
        11.8.3 Sanofi Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Sanofi Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Sanofi Recent Developments
    11.9 Wockhardt
        11.9.1 Wockhardt Corporation Information
        11.9.2 Wockhardt Overview
        11.9.3 Wockhardt Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Wockhardt Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Wockhardt Recent Developments
    11.10 Ypsomed
        11.10.1 Ypsomed Corporation Information
        11.10.2 Ypsomed Overview
        11.10.3 Ypsomed Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Ypsomed Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Ypsomed Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Insulin Industry Chain Analysis
    12.2 Human Insulin Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Insulin Production Mode & Process
    12.4 Human Insulin Sales and Marketing
        12.4.1 Human Insulin Sales Channels
        12.4.2 Human Insulin Distributors
    12.5 Human Insulin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Insulin Industry Trends
    13.2 Human Insulin Market Drivers
    13.3 Human Insulin Market Challenges
    13.4 Human Insulin Market Restraints
14 Key Findings in The Global Human Insulin Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Human Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Insulin Analogs and Biosimilars
    Table 3. Major Manufacturers of Human Insulin Biologics
    Table 4. Global Human Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Human Insulin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Human Insulin Sales by Region (2017-2022) & (K Doses)
    Table 7. Global Human Insulin Sales Market Share by Region (2017-2022)
    Table 8. Global Human Insulin Sales by Region (2023-2028) & (K Doses)
    Table 9. Global Human Insulin Sales Market Share by Region (2023-2028)
    Table 10. Global Human Insulin Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Human Insulin Revenue Market Share by Region (2017-2022)
    Table 12. Global Human Insulin Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Human Insulin Revenue Market Share by Region (2023-2028)
    Table 14. Global Human Insulin Sales by Manufacturers (2017-2022) & (K Doses)
    Table 15. Global Human Insulin Sales Share by Manufacturers (2017-2022)
    Table 16. Global Human Insulin Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Human Insulin Revenue Share by Manufacturers (2017-2022)
    Table 18. Human Insulin Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 19. Global Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin as of 2021)
    Table 21. Human Insulin Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Human Insulin Product Offered
    Table 23. Date of Manufacturers Enter into Human Insulin Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Human Insulin Sales by Type (2017-2022) & (K Doses)
    Table 26. Global Human Insulin Sales by Type (2023-2028) & (K Doses)
    Table 27. Global Human Insulin Sales Share by Type (2017-2022)
    Table 28. Global Human Insulin Sales Share by Type (2023-2028)
    Table 29. Global Human Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Human Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Human Insulin Revenue Share by Type (2017-2022)
    Table 32. Global Human Insulin Revenue Share by Type (2023-2028)
    Table 33. Human Insulin Price by Type (2017-2022) & (USD/Dose)
    Table 34. Global Human Insulin Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 35. Global Human Insulin Sales by Application (2017-2022) & (K Doses)
    Table 36. Global Human Insulin Sales by Application (2023-2028) & (K Doses)
    Table 37. Global Human Insulin Sales Share by Application (2017-2022)
    Table 38. Global Human Insulin Sales Share by Application (2023-2028)
    Table 39. Global Human Insulin Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Human Insulin Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Human Insulin Revenue Share by Application (2017-2022)
    Table 42. Global Human Insulin Revenue Share by Application (2023-2028)
    Table 43. Human Insulin Price by Application (2017-2022) & (USD/Dose)
    Table 44. Global Human Insulin Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 45. North America Human Insulin Sales by Type (2017-2022) & (K Doses)
    Table 46. North America Human Insulin Sales by Type (2023-2028) & (K Doses)
    Table 47. North America Human Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Human Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Human Insulin Sales by Application (2017-2022) & (K Doses)
    Table 50. North America Human Insulin Sales by Application (2023-2028) & (K Doses)
    Table 51. North America Human Insulin Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Human Insulin Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Human Insulin Sales by Country (2017-2022) & (K Doses)
    Table 54. North America Human Insulin Sales by Country (2023-2028) & (K Doses)
    Table 55. North America Human Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Human Insulin Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Human Insulin Sales by Type (2017-2022) & (K Doses)
    Table 58. Europe Human Insulin Sales by Type (2023-2028) & (K Doses)
    Table 59. Europe Human Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Human Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Human Insulin Sales by Application (2017-2022) & (K Doses)
    Table 62. Europe Human Insulin Sales by Application (2023-2028) & (K Doses)
    Table 63. Europe Human Insulin Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Human Insulin Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Human Insulin Sales by Country (2017-2022) & (K Doses)
    Table 66. Europe Human Insulin Sales by Country (2023-2028) & (K Doses)
    Table 67. Europe Human Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Human Insulin Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Human Insulin Sales by Type (2017-2022) & (K Doses)
    Table 70. Asia Pacific Human Insulin Sales by Type (2023-2028) & (K Doses)
    Table 71. Asia Pacific Human Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Human Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Human Insulin Sales by Application (2017-2022) & (K Doses)
    Table 74. Asia Pacific Human Insulin Sales by Application (2023-2028) & (K Doses)
    Table 75. Asia Pacific Human Insulin Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Human Insulin Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Human Insulin Sales by Region (2017-2022) & (K Doses)
    Table 78. Asia Pacific Human Insulin Sales by Region (2023-2028) & (K Doses)
    Table 79. Asia Pacific Human Insulin Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Human Insulin Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Human Insulin Sales by Type (2017-2022) & (K Doses)
    Table 82. Latin America Human Insulin Sales by Type (2023-2028) & (K Doses)
    Table 83. Latin America Human Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Human Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Human Insulin Sales by Application (2017-2022) & (K Doses)
    Table 86. Latin America Human Insulin Sales by Application (2023-2028) & (K Doses)
    Table 87. Latin America Human Insulin Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Human Insulin Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Human Insulin Sales by Country (2017-2022) & (K Doses)
    Table 90. Latin America Human Insulin Sales by Country (2023-2028) & (K Doses)
    Table 91. Latin America Human Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Human Insulin Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Human Insulin Sales by Type (2017-2022) & (K Doses)
    Table 94. Middle East and Africa Human Insulin Sales by Type (2023-2028) & (K Doses)
    Table 95. Middle East and Africa Human Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Human Insulin Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Human Insulin Sales by Application (2017-2022) & (K Doses)
    Table 98. Middle East and Africa Human Insulin Sales by Application (2023-2028) & (K Doses)
    Table 99. Middle East and Africa Human Insulin Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Human Insulin Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Human Insulin Sales by Country (2017-2022) & (K Doses)
    Table 102. Middle East and Africa Human Insulin Sales by Country (2023-2028) & (K Doses)
    Table 103. Middle East and Africa Human Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Human Insulin Revenue by Country (2023-2028) & (US$ Million)
    Table 105. B. Braun Corporation Information
    Table 106. B. Braun Description and Major Businesses
    Table 107. B. Braun Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 108. B. Braun Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. B. Braun Recent Developments
    Table 110. Becton, Dickinson Corporation Information
    Table 111. Becton, Dickinson Description and Major Businesses
    Table 112. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 113. Becton, Dickinson Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Becton, Dickinson Recent Developments
    Table 115. Biocon Corporation Information
    Table 116. Biocon Description and Major Businesses
    Table 117. Biocon Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 118. Biocon Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Biocon Recent Developments
    Table 120. Biodel Corporation Information
    Table 121. Biodel Description and Major Businesses
    Table 122. Biodel Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 123. Biodel Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Biodel Recent Developments
    Table 125. ELI Lilly Corporation Information
    Table 126. ELI Lilly Description and Major Businesses
    Table 127. ELI Lilly Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 128. ELI Lilly Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. ELI Lilly Recent Developments
    Table 130. Julphar Corporation Information
    Table 131. Julphar Description and Major Businesses
    Table 132. Julphar Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 133. Julphar Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Julphar Recent Developments
    Table 135. NOVO Nordisk Corporation Information
    Table 136. NOVO Nordisk Description and Major Businesses
    Table 137. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 138. NOVO Nordisk Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. NOVO Nordisk Recent Developments
    Table 140. Sanofi Corporation Information
    Table 141. Sanofi Description and Major Businesses
    Table 142. Sanofi Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 143. Sanofi Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Sanofi Recent Developments
    Table 145. Wockhardt Corporation Information
    Table 146. Wockhardt Description and Major Businesses
    Table 147. Wockhardt Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 148. Wockhardt Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Wockhardt Recent Developments
    Table 150. Ypsomed Corporation Information
    Table 151. Ypsomed Description and Major Businesses
    Table 152. Ypsomed Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 153. Ypsomed Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Ypsomed Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Human Insulin Distributors List
    Table 158. Human Insulin Customers List
    Table 159. Human Insulin Market Trends
    Table 160. Human Insulin Market Drivers
    Table 161. Human Insulin Market Challenges
    Table 162. Human Insulin Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Insulin Product Picture
    Figure 3. Global Human Insulin Market Share by Type in 2021 & 2028
    Figure 3. Insulin Analogs and Biosimilars Product Picture
    Figure 4. Human Insulin Biologics Product Picture
    Figure 5. Global Human Insulin Market Share by Application in 2021 & 2028
    Figure 6. Short Acting
    Figure 7. Intermediate Acting
    Figure 8. Long Acting
    Figure 9. Pre-Mix Insulin
    Figure 10. Human Insulin Report Years Considered
    Figure 11. Global Human Insulin Sales 2017-2028 (K Doses)
    Figure 12. Global Human Insulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Human Insulin Revenue 2017-2028 (US$ Million)
    Figure 14. Global Human Insulin Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Human Insulin Sales Market Share by Region (2017-2022)
    Figure 16. Global Human Insulin Sales Market Share by Region (2023-2028)
    Figure 17. North America Human Insulin Sales YoY (2017-2028) & (K Doses)
    Figure 18. North America Human Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Human Insulin Sales YoY (2017-2028) & (K Doses)
    Figure 20. Europe Human Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Human Insulin Sales YoY (2017-2028) & (K Doses)
    Figure 22. Asia-Pacific Human Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Human Insulin Sales YoY (2017-2028) & (K Doses)
    Figure 24. Latin America Human Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Human Insulin Sales YoY (2017-2028) & (K Doses)
    Figure 26. Middle East & Africa Human Insulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Human Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Human Insulin in the World: Market Share by Human Insulin Revenue in 2021
    Figure 29. Global Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Human Insulin Sales Market Share by Type (2017-2028)
    Figure 31. Global Human Insulin Revenue Market Share by Type (2017-2028)
    Figure 32. Global Human Insulin Sales Market Share by Application (2017-2028)
    Figure 33. Global Human Insulin Revenue Market Share by Application (2017-2028)
    Figure 34. North America Human Insulin Sales Market Share by Type (2017-2028)
    Figure 35. North America Human Insulin Revenue Market Share by Type (2017-2028)
    Figure 36. North America Human Insulin Sales Market Share by Application (2017-2028)
    Figure 37. North America Human Insulin Revenue Market Share by Application (2017-2028)
    Figure 38. North America Human Insulin Sales Share by Country (2017-2028)
    Figure 39. North America Human Insulin Revenue Share by Country (2017-2028)
    Figure 40. U.S. Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Human Insulin Sales Market Share by Type (2017-2028)
    Figure 43. Europe Human Insulin Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Human Insulin Sales Market Share by Application (2017-2028)
    Figure 45. Europe Human Insulin Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Human Insulin Sales Share by Country (2017-2028)
    Figure 47. Europe Human Insulin Revenue Share by Country (2017-2028)
    Figure 48. Germany Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 49. France Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Human Insulin Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Human Insulin Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Human Insulin Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Human Insulin Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Human Insulin Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Human Insulin Revenue Share by Region (2017-2028)
    Figure 59. China Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 62. India Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Human Insulin Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Human Insulin Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Human Insulin Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Human Insulin Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Human Insulin Sales Share by Country (2017-2028)
    Figure 74. Latin America Human Insulin Revenue Share by Country (2017-2028)
    Figure 75. Mexico Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Human Insulin Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Human Insulin Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Human Insulin Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Human Insulin Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Human Insulin Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Human Insulin Revenue Share by Country (2017-2028)
    Figure 84. Turkey Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Human Insulin Revenue (2017-2028) & (US$ Million)
    Figure 87. Human Insulin Value Chain
    Figure 88. Human Insulin Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
B. Braun
Becton, Dickinson
Biocon
Biodel
ELI Lilly
Julphar
NOVO Nordisk
Sanofi
Wockhardt
Ypsomed
Frequently Asked Questions
Human Insulin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Insulin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Insulin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Humectants

Humectants market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More